All In Biotech

Drug Trial Radar · NCT07076030

Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal Function

Last checked: Nov 19, 2026Latest source record: Jan 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

39

Actual

Start

Apr 15, 2025

Primary completion

Nov 25, 2025

Study completion Nov 25, 2025

Sponsor

Lead sponsor
Zealand PharmaIndustry
Sponsor type
Industry
Collaborators
ICON plc
First posted
Jul 20, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This clinical research study is testing the study compound petrelintide that is being developed for the weight management in people with obesity or overweight with comorbidities or related diseases. The aim of this clinical research study is to investigate whether the effects of petrelintide will be different in people with normal kidney function compared to people with impaired kidney function.

Conditions

  • Renal Impairment

Interventions

  • PetrelintideDrug

    Solution administered with a syringe

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. AUCo-inf of petrelintideTime frame: From administration (Day 1) to Last visit (Day 43)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Charité Research Organisation GmbH

    Berlin, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.